James E. Francese - 10 Mar 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role: Sr. VP, Comm. Ops., NA, APAC
Signature: /s/ Samuel Gesten as attorney-in-fact for James Francese
Issuer symbol: STAA
Transactions as of: 10 Mar 2023
Net transactions value: -$14,158
Form type: 4
Filing time: 10 Mar 2023, 20:38:17 UTC
Previous filing: 08 Mar 2023
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STAA	Common Stock	Tax liability	$14,158	-250	-0.73%	$56.63	33,986	10 Mar 2023	Direct
transaction	STAA	Common Stock	Options Exercise	$0	+8,388	+25%	$0.000000	42,374	10 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STAA	Common Stock Options	Options Exercise	$0	+15,339		$0.000000	15,339	10 Mar 2023	Common Stock	15,339	$56.63	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award of 8388 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/10/2024, 1/3 of the RSUs on 3/10/2025, and the remaining 1/3 of the RSUs on 3/10/2026.
F2	The options granted become exercisable as follows: 1/3 on 3/10/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/10/2026.